Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

Conditions:   Aplastic Anemia;   Hypoplastic Myelodysplastic Syndrome
Interventions:   Drug: BL-8040;   Drug: horse anti-thymocyte globulin (hATG);   Drug: Methylprednisolone;   Drug: Cyclosporine
Sponsor:   BioLineRx, Ltd.
Recruiting - verified June 2016
News Type: